Erratum: Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia (Cancer (2013) 119 (90-8))

W. Stock, J. L. Johnson, R. M. Stone, J. E. Kolitz, B. L. Powell, M. Wetzler, P. Westervelt, G. Marcucci, D. J. DeAngelo, J. W. Vardiman, D. McDonnell, K. Mrõzek, C. D. Bloomfield, R. A. Larson

Research output: Contribution to journalComment/debate

Original languageEnglish
Number of pages1
JournalCancer
Volume120
Issue number14
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Cite this

Stock, W., Johnson, J. L., Stone, R. M., Kolitz, J. E., Powell, B. L., Wetzler, M., Westervelt, P., Marcucci, G., DeAngelo, D. J., Vardiman, J. W., McDonnell, D., Mrõzek, K., Bloomfield, C. D., & Larson, R. A. (2014). Erratum: Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia (Cancer (2013) 119 (90-8)). Cancer, 120(14). https://doi.org/10.1002/cncr.28708